Innoviva (INVA) Non-Current Assets (2010 - 2026)

Innoviva (INVA) posted Non-Current Assets of $1.1 billion for Q1 2026, up 17.22% on a QoQ basis from $907.6 million in Q4 2025, and up 58.24% year-over-year from $672.4 million in Q1 2025.

Innoviva (INVA) Non-Current Assets (2010 - 2026) Analysis & Trends

Innoviva's Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

  • Quarterly Non-Current Assets rose 58.24% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 billion (up 2.58% YoY) and the FY2025 annual result came in at $907.6 million, up 21.55% from the prior year.
  • Non-Current Assets was $1.1 billion for Q1 2026 at Innoviva, up from $907.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.1 billion in Q1 2026 and bottomed at $59.6 million in Q3 2022.
  • A 5-year average of $557.1 million and a median of $737.3 million in 2022 frame the typical range for Non-Current Assets.
  • Peak annual rise in Non-Current Assets reached 5746.67% in 2022, while the deepest fall reached 90.27% in 2022.
  • Innoviva's Non-Current Assets stood at $59.6 million in 2022, then advanced by 27.73% to $76.2 million in 2023, then surged by 880.3% to $746.8 million in 2024, then grew by 21.55% to $907.6 million in 2025, then gained by 17.22% to $1.1 billion in 2026.
  • Business Quant data shows INVA's Non-Current Assets at $1.1 billion in Q1 2026, $907.6 million in Q4 2025, and $72.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Innoviva 1.57 Bn 969.11 Mn 75.83 Mn 1.06 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.06 Bn
Dec 31, 2025 907.65 Mn
Sep 30, 2025 72.59 Mn
Jun 30, 2025 681.79 Mn
Mar 31, 2025 672.37 Mn
Dec 31, 2024 746.75 Mn
Sep 30, 2024 75.85 Mn
Jun 30, 2024 866.64 Mn
Mar 31, 2024 956.27 Mn
Dec 31, 2023 76.18 Mn
Sep 30, 2023 76.18 Mn
Jun 30, 2023 794.70 Mn
Mar 31, 2023 833.32 Mn
Dec 31, 2022 59.64 Mn
Sep 30, 2022 59.64 Mn
Jun 30, 2022 737.31 Mn
Mar 31, 2022 789.65 Mn
Dec 31, 2021 612.72 Mn
Sep 30, 2021 1.02 Mn
Jun 30, 2021 640.89 Mn